Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Planet Labs
PL
$8.82B
| $2.65M | ﹤0.01% |
434,410
+169,827
| +64% | +$694K |
|
2602
PUT
Airbnb
ABNB
$111B
| $2.65M | ﹤0.01% |
20,000
-137,900
| -87% | -$17.5M |
|
2603
Collegium Pharmaceutical
COLL
$913M
| $2.64M | ﹤0.01% |
89,434
+15,731
| +21% | +$449K |
|
2604
UiPath
PATH
$8.64B
| $2.64M | ﹤0.01% |
206,261
-4,999
| -2% | -$60K |
|
2605
Diebold Nixdorf
DBD
$2.45B
| $2.64M | ﹤0.01% |
47,634
+19,013
| +66% | +$892K |
|
2606
PUT
Match Group
MTCH
$8.56B
| $2.64M | ﹤0.01% |
85,400
| – | – |
|
2607
CALL
Xerox
XRX
$412M
| $2.63M | ﹤0.01% |
+500,000
| New | +$2.44M |
|
2608
Ziff Davis
ZD
$1.92B
| $2.63M | ﹤0.01% |
87,030
+29,985
| +53% | +$964K |
|
|
MRC
2609
DELISTED
MRC Global
MRC
| $2.63M | ﹤0.01% |
191,997
-250,652
| -57% | -$3.02M |
|
2610
Dentsply Sirona
XRAY
$2.31B
| $2.63M | ﹤0.01% |
165,409
+32,308
| +24% | +$483K |
|
2611
Lionsgate Studios
LION
$3.49B
| $2.63M | ﹤0.01% |
452,095
+409,675
| +966% | +$2.74M |
|
2612
Evolv Technologies
EVLV
$1.04B
| $2.62M | ﹤0.01% |
420,613
+253,861
| +152% | +$1.17M |
|
2613
Marcus & Millichap
MMI
$1.2B
| $2.62M | ﹤0.01% |
85,401
+28,909
| +51% | +$877K |
|
2614
Anavex Life Sciences
AVXL
$303M
| $2.62M | ﹤0.01% |
284,259
+135,584
| +91% | +$1.16M |
|
2615
CALL
Aurora
AUR
$13.4B
| $2.62M | ﹤0.01% |
+500,000
| New | +$3.14M |
|
|
2616
PUT
Aurora
AUR
$13.4B
| $2.62M | ﹤0.01% |
+500,000
| New | +$3.14M |
|
2617
German American Bancorp
GABC
$1.92B
| $2.62M | ﹤0.01% |
68,002
+31,108
| +84% | +$1.17M |
|
2618
Credit Acceptance
CACC
$6.05B
| $2.62M | ﹤0.01% |
5,140
+1,789
| +53% | +$879K |
|
2619
Kforce
KFRC
$1.08B
| $2.6M | ﹤0.01% |
63,284
+10,069
| +19% | +$422K |
|
2620
TriCo Bancshares
TCBK
$1.86B
| $2.6M | ﹤0.01% |
64,158
+18,281
| +40% | +$718K |
|
|
AAT
2621
American Assets Trust
AAT
$1.41B
| $2.6M | ﹤0.01% |
131,522
+39,240
| +43% | +$763K |
|
2622
VF Corp
VFC
$5.79B
| $2.59M | ﹤0.01% |
220,712
-273,672
| -55% | -$3.39M |
|
2623
Bruker
BRKR
$8.83B
| $2.59M | ﹤0.01% |
62,867
-37,996
| -38% | -$1.47M |
|
2624
DHT Holdings
DHT
$3.09B
| $2.59M | ﹤0.01% |
239,281
+80,254
| +50% | +$885K |
|
2625
Kirby Corp
KEX
$7.26B
| $2.59M | ﹤0.01% |
22,798
+2,230
| +11% | +$234K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.